Foamix Pharmaceuticals Ltd. Financing Cash Flow
Foamix Pharmaceuticals Ltd. reported Financing Cash Flow of $47.95 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was $20.00M, a 166533.33% increase year-over-year.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was $27.94M, a 62.94% decline year-over-year.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for the quarter ending 2019-06-30 was $2.00K.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for the quarter ending 2019-03-31 was $16.00K.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for fiscal 2019 was $47.95M, a 48.09% decline from fiscal 2018.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for fiscal 2018 was $92.37M, a 65881.43% increase from fiscal 2017.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for fiscal 2017 was $140.00K, a 99.75% decline from fiscal 2016.
- Foamix Pharmaceuticals Ltd. net cash provided by (used in) financing activities for fiscal 2016 was $55.03M, a 17.62% decline from fiscal 2015.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $47.93M derived: sum of 2 quarters · filed 2020-03-12 | $47.93M derived: sum of 3 quarters · filed 2020-03-12 | $47.95M 10-K · filed 2020-03-12 |
| 2019-09-30 | $27.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $27.94M derived: sum of 2 quarters · filed 2019-11-12 | $27.95M 10-Q · filed 2019-11-12 | $27.97M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $18.00K 10-Q · filed 2019-08-07 | $30.00K derived: sum of 3 quarters · filed 2020-03-12 | $75.41M derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | $16.00K 10-Q · filed 2019-05-07 | $28.00K derived: sum of 2 quarters · filed 2020-03-12 | $75.41M derived: sum of 3 quarters · filed 2020-03-12 | |
| 2018-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $75.39M derived: sum of 2 quarters · filed 2020-03-12 | $92.37M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $75.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $92.36M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $16.98M 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $11.00K derived: sum of 2 quarters · filed 2020-03-12 | $11.00K derived: sum of 3 quarters · filed 2020-03-12 | $140.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$5.00K derived: sum of 2 quarters · filed 2018-11-07 | $124.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $129.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $129.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $55.03M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $66.80M 10-K · filed 2018-03-01 |